Marrone Bio Innovations Inc (MBII) Forecast, Price Target & Analyst Ratings

NASDAQ:MBII • US57165B1061

Current stock price

0.7981
-0.2 (-20.19%)
At close:
0.81
+0.01 (+1.49%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Marrone Bio Innovations Inc (MBII).

Forecast Snapshot

Consensus Price Target

Price Target
$1.40
+ 75.73% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 15, 2022
Period
Q2 / 2022
EPS Estimate
-$0.04
Revenue Estimate
16.32M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.40
Upside
+ 75.73%
From current price of $0.80 to mean target of $1.40, Based on 10 analyst forecasts
Low
$0.91
Median
$1.33
High
$2.10

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for MBII. The average price target is 1.4 null. This implies a price increase of 75.73% is expected in the next year compared to the current price of 0.7981.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MBII Current Analyst RatingMBII Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MBII Historical Analyst RatingsMBII Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
MBII was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about MBII.
In the previous month the buy percentage consensus was at a similar level.
MBII was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-09-22Roth CapitalInitiate Buy
2021-08-19Aegis CapitalMaintains Buy
2021-02-11Aegis CapitalMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 15, 2022
Period
Q2 / 2022
EPS Estimate
-$0.04
Revenue Estimate
16.32M
Revenue Q2Q
29.52%
EPS Q2Q
-104.00%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

MBII is expected to report earnings on 8/15/2022. The consensus EPS estimate for the next earnings is -0.04 null and the consensus revenue estimate is 16.32M null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
MBII revenue by date.MBII revenue by date.
29.37M
38.41%		38.37M
30.64%		44.31M
15.48%		57.579M
29.95%		72.42M
25.78%		91.8M
26.76%		113.641M
23.79%		143.492M
26.27%
EBITDA
YoY % growth
MBII ebitda by date.MBII ebitda by date.
-25.64M
-45.52%		-13.64M
46.80%		-11.87M
12.98%		-4.026M
66.08%		4.182M
203.86%		3.049M
-27.10%		2.267M
-25.64%		N/A
EBIT
YoY % growth
MBII ebit by date.MBII ebit by date.
-27.99M
-43.46%		-17.2M
38.55%		-15.4M
10.47%		-12.954M
15.88%		-3.57M
72.44%		-4.971M
-39.25%		-7.061M
-42.03%		N/A
Operating Margin
MBII operating margin by date.MBII operating margin by date.
-95.30%-44.83%-34.76%-22.50%-4.93%-5.42%-6.21%N/A
EPS
YoY % growth
MBII eps by date.MBII eps by date.
-0.27
-55.71%		-0.15
44.44%		-0.10
33.33%		-0.11
-7.10%		-0.02
80.95%		-0.02-0.03
-37.72%		-0.04
-40.48%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-0.04
-104.00%		-0.04
-36.00%		-0.04
-36.00%
Revenue
Q2Q % growth		16.32M
29.52%		15.606M
58.28%		13.77M
27.26%
EBITDA
Q2Q % growth		-102K
83.28%		306K
117.29%		-102K
95.10%
EBIT
Q2Q % growth		-1.836M
22.20%		-2.04M
53.74%		-1.938M
65.45%

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MBII Yearly Revenue VS EstimatesMBII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
MBII Yearly EPS VS EstimatesMBII Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.55%
EPS Next 5 Year
9.93%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
27.21%
Revenue Next 5 Year
26.33%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Marrone Bio Innovations Inc / MBII Forecast FAQ

Can you provide the average price target for Marrone Bio Innovations Inc stock?

10 analysts have analysed MBII and the average price target is 1.4 null. This implies a price increase of 75.73% is expected in the next year compared to the current price of 0.7981.

When does Marrone Bio Innovations Inc (MBII) report earnings?

Marrone Bio Innovations Inc (MBII) will report earnings on 2022-08-15, after the market close.

Can you provide the consensus estimates for Marrone Bio Innovations Inc next earnings?

The consensus EPS estimate for the next earnings of Marrone Bio Innovations Inc (MBII) is -0.04 null and the consensus revenue estimate is 16.32M null.

What is the expected long term growth rate for Marrone Bio Innovations Inc (MBII)?

The expected long term growth rate for Marrone Bio Innovations Inc (MBII) is 27.21%.